Medical BooksProcess Development of Amlodipine and Olmesartan Medoxomil Tablets
Item 1 of 1
Item 1 of 1
SKU 9786203409338Publishing Ref 9786203409338
LAP Lambert Academic Publishing
Process Development of Amlodipine and Olmesartan Medoxomil Tablets
Printed Book
SR 186
Inclusive of VAT
Sold as: EACH
SKU 9786203409338Publishing Ref 9786203409338
Author:Behera, Gayatri
Date of Publication: 2021
Book classification:Medical Books,English Books,
No. of pages:72 Pages
Format:Paperback
This book is printed on demand and is non-refundable after purchase
Available Formats :
Printed Book
It will be sent to your address
SR186
Incl. VAT
Choose your delivery preference
Secure Shopping
Convenient Returns
Genuine & Warranted
Fast Delivery
Or
About this Product
The present study was focused on process development of amlodipine and olmesartan medoxomil tablet 10/40mg. Amlodipine and Olmesartan medoxomil is a combination of a calcium channel blocker and an angiotensin II receptor antagonist used to treat high blood pressure . The Content uniformity was found of both the drugs were performed. Release study was conducted in pH 6.8 buffer media. Furthermore, dissolution profile comparison was carried out using similarity factor (f2) and the similarity factor of Amlodipine and Olmesartan Medoxomil found to be 73. Other studies Like DSC and FTIR studies reported compatibility of Amlodipine besylate with excipients like Cross Carmel lose sodium was performed shows no chemical interaction between drug and excipients. Dissolution profile of Test and Reference standard found to be similar, Similarity factor (f2) is 73.